CN1106268A - 治疗白血病的中草药组合物及其逆转细胞汤的制备方法 - Google Patents
治疗白血病的中草药组合物及其逆转细胞汤的制备方法 Download PDFInfo
- Publication number
- CN1106268A CN1106268A CN93120412A CN93120412A CN1106268A CN 1106268 A CN1106268 A CN 1106268A CN 93120412 A CN93120412 A CN 93120412A CN 93120412 A CN93120412 A CN 93120412A CN 1106268 A CN1106268 A CN 1106268A
- Authority
- CN
- China
- Prior art keywords
- radix
- steams
- water
- cell
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000032839 leukemia Diseases 0.000 title abstract description 10
- 235000008216 herbs Nutrition 0.000 title description 2
- 239000003814 drug Substances 0.000 claims abstract description 20
- 239000000203 mixture Substances 0.000 claims abstract description 8
- 235000014347 soups Nutrition 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- 210000002700 urine Anatomy 0.000 claims description 6
- 239000002131 composite material Substances 0.000 claims description 5
- 241000208340 Araliaceae Species 0.000 claims description 4
- 241001236122 Coprinopsis atramentaria Species 0.000 claims description 4
- 241000565633 Coprinus sterquilinus Species 0.000 claims description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 244000309464 bull Species 0.000 claims description 4
- 235000008434 ginseng Nutrition 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 235000013599 spices Nutrition 0.000 claims description 4
- 241000628997 Flos Species 0.000 claims description 2
- 241001251068 Formica fusca Species 0.000 claims description 2
- 244000273928 Zingiber officinale Species 0.000 claims description 2
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 2
- 235000008397 ginger Nutrition 0.000 claims description 2
- 238000001802 infusion Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 239000000052 vinegar Substances 0.000 claims description 2
- 235000021419 vinegar Nutrition 0.000 claims description 2
- 230000036039 immunity Effects 0.000 abstract description 7
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003394 haemopoietic effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 26
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 230000002441 reversible effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 5
- 210000001185 bone marrow Anatomy 0.000 description 5
- 238000002512 chemotherapy Methods 0.000 description 5
- 210000000265 leukocyte Anatomy 0.000 description 5
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 4
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 4
- 230000000366 juvenile effect Effects 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 239000011651 chromium Substances 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 230000002607 hemopoietic effect Effects 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 208000028399 Critical Illness Diseases 0.000 description 2
- 208000036566 Erythroleukaemia Diseases 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000000729 antidote Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 210000003298 dental enamel Anatomy 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
- 206010000871 Acute monocytic leukaemia Diseases 0.000 description 1
- 208000036762 Acute promyelocytic leukaemia Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000031637 Erythroblastic Acute Leukemia Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010058490 Hyperoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 208000035489 Monocytic Acute Leukemia Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- 208000033826 Promyelocytic Acute Leukemia Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000021841 acute erythroid leukemia Diseases 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000010322 bone marrow transplantation Methods 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000000222 hyperoxic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- JZWFDVDETGFGFC-UHFFFAOYSA-N salacetamide Chemical group CC(=O)NC(=O)C1=CC=CC=C1O JZWFDVDETGFGFC-UHFFFAOYSA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- 150000003538 tetroses Chemical class 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及一种治疗白血病的中草药组合物及其逆转细胞汤的制备方法,它以多种中草药为主料制成,是一种新型人体复合性免疫、调节、解毒剂,患者服用该药即可得到有效治疗,能够避免西药化疗的副作用,提高造血功能,增强免疫力。在动物试验的基础上又进行了数百例临床验证,临床验证取得了意想不到的效果,随机治疗各类白血病患者180例,痊愈率25%,总有效率达93.9%。
Description
本发明涉及一种治疗白血病的中草药组合物,及用该组合物制备逆转细胞汤的方法。
目前,国内外治疗白血病这一疑难病症一般临床使用化疗,化疗能在一定程度上使患者病情缓解,但西医化疗法治疗白血病,在大量杀死癌细胞的同时,也杀伤了许多正常细胞,使患者心、肝、脾、肾及消化系统均受到不同程度的损害,抵抗力下降,机能减退,往往使病情得不到有效控制和治疗。
同时,不少大医院临床上也采用了异体骨髓移植、自身骨髓移植、混体移植治疗等,其疗效各异,但内脏腑积毒难消,感染尚存,且往往还需要配合化疗。中国医学科学院血液研究所研制的植物导弹制治疗白血病,此药仅能降低化疗药物的毒性,提高药物杀伤癌细胞的作用,属于辅助治疗药物。
本发明的目的在于提供一种治疗白血病的中草药组合物,以及用该组合物制备中药汤剂一逆转细胞汤的方法,以便白血病患者服用该药即可得到有效治疗,避免化疗的付作用,减少患者痛苦,提高患者造血功能,增强其免疫力。
本发明的中草药组合物配方如下:
鬼盖5-10g 人参3-10g
苍术5-10g 甘草10-25g
芸苔子花2-10g 犀角(或水牛角)1-2g
当归5-15g 白芍5-10g
石榴花2-10g 生地10-25g
川芎5-10g 菟丝子10-25g
苜蓿紫花2-5g。
按照上述中草药组合物制备中药汤剂一逆转细胞汤的方法是:
按配方配药,单味药预炮制,向药料中加水,加入引子,每付药引子的加入量为:白马溺30g、干姜粉10g、柳叶粉20g、蚂蚁粉0.6g,用砂锅或搪瓷反应釜加热煎煮20-30分钟,然后取出药液经过滤即成。
上述药料的加水量为每付药800g左右。
上述单味药预炮制过程如下:
鬼盖用童尿浸泡,人参用童尿蒸制,苍术盐炒,甘草用朱砂水飞浸湿,以童尿拌入芸苔子花中,当归蒸制30分钟,白芍用麦麸炒制后加入醋,生地中加入鹿血水蒸制20分钟,川芎中加入鹿血水蒸制20分钟,菟丝子用盐水泡制,以盐水拌入苜蓿紫花中。
上述逆转细胞汤大量生产时可用搪瓷反应釜加热煎煮加工,患者自用可用砂锅煎煮。本中药组合物还可制成散剂、片剂、丸剂等。
本中药制品是一种新型人体复合性免疫、调节、解毒剂,内含:生物碱、皂甙、氨基酸、高氧酸、水杨基酸、磷、钙及多种微量元素,如铁、铜、锰、锌、镍、铬……等。本发明的逆转细胞汤经中国林科院分析中心分析,其成份如表一所示。其经临床验证可以使血癌细胞孤离分消,透毒转化,防止体内毒素积聚,温毒内陷,提高造血功能,增强人体免疫力。
本发明的积极效果如下:
1、本发明的中药制品是一种人体复合性免疫、调节、解毒剂,白血病患者服用该药即可得到有效治疗,避免了化疗付作用,毒性小,服用方便,减少了患者痛苦,提高了患者造血功能,增强了其免疫力,使白血病积毒细胞孤离分消,转化更新,达到治愈之目的。
2、本发明的中药制品逆转细胞汤与本所研制的另一种中药汤剂-再生细胞汤用于治疗各种白血病,经临床验证取的了意想不到的效果。
1983年-1991年,随机治疗急性、复发性白血病晚期患者180例,其中急性粒细胞白血病49例,急性粒单细胞白血病21例,急性早幼粒细胞白血病15例,急性红白血病4例,急性单核细胞白血病22例,急性淋巴细胞白血病41例,慢性粒细胞白血病28例;年龄最大68岁,最小2.5岁;男姓102例,女姓78例。痊愈率25%,基本痊愈(部分缓解)率68.9%,无效率6.1%,总有效率达93.9%。
近年来,接受本发明治疗的白血病患者遍及全国16省市,发明者陈齐文大夫被患者、亲友誉为“神医”、“华佗再世”。
以下举几例典型病例说明。
例1:陕西省 尉×× 男 32岁 干部
88年4月西安市中心医院骨髓检查报告结果:原始细胞加幼稚细胞达80.5%,急性粒细胞白血病(M2.2型);血常规检查结果:血色素5.56g,红细胞176万/mm3,血小板0.8万mm3,白细胞700/mm3。88年5月入院时,患者生命垂危,以清热、解毒、扶正、祛邪治疗法,服逆转细胞汤等治疗痊愈。
88年8月,经西安市中心医院、血液病研究等检查,骨髓检查报告结果:原始细胞加幼稚细胞下降到3.5%;血常规检查结果:血色素12g,红细胞447万/mm3,白细胞8800/mm3。患者痊愈后已正常工作四年多。
例2:北京市 陈×× 男 12岁 学生
88年8月北京医科大学第三医院骨髓检查报告结果:原始细胞加幼稚细胞59%,急性粒细胞白血病(M2型);血常规检查结果:血色素10.2g,血小板118000/mm3,……服用本发明逆转细胞汤及再生细胞汤等后痊愈。
91年7月-92年4月,中国中医研究院西苑医院,两次骨髓检查报告结果:原始细胞先后下降到4.5%、1.25%,幼稚细胞先后下降到3.5%、0.5%,急性粒细胞白血病缓解;血常规检查结果:血色素12.8g,白细胞7300/mm3。中性分叶66/mm3,淋巴27/mm3。
例3:山西省 高×× 女 27岁 农民
86年6月运城血液研究所检查为红白血病(M6型),骨髓检查报告结果:原始细胞47%;血常规检查结果:血色素4.5g,白细胞2000/mm3,血小板2.3万/mm3;入院时患者体温40.5℃,脉搏120次/分,血压75/50mmg。高烧不退,脉数无力,神态不清,已处病危。服用本发明的药品两月后痊愈。
86年8月血常规检查结果:血色素12g,血小板17万/mm3,白细胞6600/mm3。患者于89年2月生一男孩,后经血液病院多次检查,母子身体正常,至今已七年之久,患者病情未复发。
3、山西运城地区药品检验所对本发明的逆转细胞汤安全试验结果如下:取逆转细胞汤0.8ml给17-20g健康小白鼠口服灌胃(相等于人用量50倍),观察72小时未见死之。
表一
氯基酸mg/100ml | 微量元素 | 糖g/100g | |||
天门冬氨基酸 | 101.914 | 镍(Ni)μg/ml | 1.17 | 多糖 | 3.046 |
苏氨酸 | 10.536 | 锂(Li)μg/ml | 0.49 | 四糖 | 0.217 |
丝氨酸 | 15.664 | 钴(Co)μg/ml | 0.24 | 三糖 | 0.174 |
谷氨酸 | 94.851 | 锶(Sr)μg/ml | 1.46 | 蔗糖 | 0.820 |
甘氨酸 | 16.920 | 钼(Mo)μg/ml | 0.42 | 葡萄糖 | 1.100 |
丙氨酸 | 18.074 | 锗(Ge)μg/ml | 0.064 | 果糖 | 2.500 |
缬氨酸 | 10.519 | 硒(Se)μg/ml | 0.113 | 总游离糖 | 11.414 |
蛋氨酸 | 2.766 | 硼(B)μg/ml | 3.71 | mg/100g | |
异亮氨酸 | 9.111 | 硫(S)μg/ml | 1037.1 | 总有机酸 | 854.20 |
亮氨酸 | 16.245 | 磷(P)μg/ml | 1060.9 | 果胶 | 380.90 |
酪氨酸 | 14.250 | 钾(K)g/100ml | 0.323 | 单宁 | 201.60 |
苯丙氨酸 | 17.812 | 钠(Na)g/100ml | 0.096 | 总皂甙 | 183.80 |
组氨酸 | 18.585 | 钙(Ca)g/100ml | 0.025 | 总生物碱 | 322.80 |
赖氨酸 | 11.406 | 镁(Mg)g/100ml | 0.036 | VE | 0.66 |
精氨酸 | 16.881 | 铜(Cu)μg/ml | 0.980 | β-胡罗卜素 | 0.04 |
色氨酸 | 4.106 | 锌(Zu)μg/ml | 3.11 | ||
胱氨酸 | 18.000 | 铁(Fe)μg/ml | 69.5 | ||
锰(Mn)μg/ml | 6.64 | ||||
铬(Cr)μg/ml | 0.267 | ||||
氟(F)μg/ml | 5.05 | ||||
铅(Pb)μg/ml | 0.87 | ||||
汞(Hg)μg/ml | 0.174 | ||||
砷(As)μg/ml | 45.6 | ||||
灰分g/100ml | 0.979 | ||||
总计 | 397.640 |
Claims (6)
1、一种治疗白血病的中草药组合物,其特征在于该组合物配方为:
鬼盖 5-10g 人参 3-10g
苍术 5-10g 甘草 10-25g
芸苔子花 2-10g 犀角(或水牛角) 1-2g
当归 5-15g 白芍 5-10g
石榴花 2-10g 生地 10-25g
川芎 5-10g 菟丝子 10-25g
苜蓿紫花 2-5g。
2、按照权利要求1的中草药组合物制备其逆转细胞汤的方法,其特征在于采取如下步骤:
a、按配方配药;
b、单味药预炮制;
c、加水;
d、加入引子;
e、加热煎煮;
f、取药液过滤。
3、根据权利要求2所述的方法,其特征在于所述单味药预炮制过程如下:
鬼盖用童尿浸泡,人参用童尿蒸制,苍术盐炒,甘草用朱砂水飞浸湿,以童尿拌入芸苔子花中,当归蒸制30分钟,白芍用麦麸炒制后加入醋,生地中加入鹿血水蒸制20分钟,川芎中加入鹿血水蒸制20分钟,菟丝子用盐水泡制,以盐水拌入苜蓿紫花中。
4、根据权利要求2所述的方法,其特征在于:药料的加水量为每付药800g左右。
5、根据权利要求2所述的方法,其特征在于药料的加热煎煮时间为20-30分钟。
6、根据权利要求2所述的方法,其特征在于:所述的引子每付药加入量:为白马溺30g、干姜粉10g、柳叶粉20g、蚂蚁粉0.6g。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN93120412A CN1050515C (zh) | 1992-12-18 | 1993-12-11 | 一种治疗白血病的中药组合物及其制法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN92114509 | 1992-12-18 | ||
CN92114509.8 | 1992-12-18 | ||
CN93120412A CN1050515C (zh) | 1992-12-18 | 1993-12-11 | 一种治疗白血病的中药组合物及其制法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1106268A true CN1106268A (zh) | 1995-08-09 |
CN1050515C CN1050515C (zh) | 2000-03-22 |
Family
ID=25742871
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN93120412A Expired - Fee Related CN1050515C (zh) | 1992-12-18 | 1993-12-11 | 一种治疗白血病的中药组合物及其制法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1050515C (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100366276C (zh) * | 2006-03-22 | 2008-02-06 | 郭占山 | 一种调节血细胞的状态、提高免疫力的药物 |
-
1993
- 1993-12-11 CN CN93120412A patent/CN1050515C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1050515C (zh) | 2000-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103041317B (zh) | 一种治疗肿瘤的中药组合物及其制备方法 | |
CN101711848B (zh) | 一种辅助治疗肿瘤的中药组合物 | |
CN102145128A (zh) | 一种防治心脑血管疾病的药物组合物及其制备方法 | |
CN103223131B (zh) | 肝病药物 | |
WO2002089827A1 (en) | Composition for the prophylaxis or treatment of male reproductivity depression, or for the stimulation of haematogenesis | |
CN1268370C (zh) | 补肾壮阳胶囊 | |
GB2581592A (en) | Preparation procedure for panax notoginseng medicinal liquor for oral administration for treating rheumatic ostalgia | |
CN101524470A (zh) | 一种防治心血管疾病支架再狭窄的中药制剂及制备方法 | |
CN1173726C (zh) | 一种治疗恶性肿瘤病的药物及其制备方法 | |
CN101474388B (zh) | 一种改进的仙蟾片药物处方及其制备方法 | |
CN105434738A (zh) | 一种治疗小儿多动症的中药组合物及其制备方法 | |
CN1052408C (zh) | 一种治疗白血病的中草药组合物及其制备方法 | |
CN1106268A (zh) | 治疗白血病的中草药组合物及其逆转细胞汤的制备方法 | |
CN1085439A (zh) | 一种抗癌中草药 | |
CN101199667A (zh) | 一种治疗白血病、再生障碍性贫血的中药制剂 | |
CN1144595C (zh) | 抗癌胶囊及其制备方法 | |
CN111544522A (zh) | 一种治疗消化道肿瘤引发贫血的中药组合物及其制备方法 | |
CN1201811C (zh) | 一种治疗近视眼的中药组合物及制法 | |
CN1098698C (zh) | 治疗白血病的药物及其制备方法 | |
CN1063074C (zh) | 一种治疗肿瘤的中药注射液及制造方法 | |
CN106237156A (zh) | 一种治疗胃癌的中药组合物及其制备方法 | |
CN1058882C (zh) | 一种治疗肿瘤的口服液及其制备方法 | |
CN1080563C (zh) | 向日葵秆芯作为制备治疗癌症的药剂的用途 | |
CN106389647A (zh) | 一种治疗血液病的药物 | |
CN1060359C (zh) | 一种治疗慢性疲劳综合征的纯中药制剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |